Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy.
Department of Cardiac Surgery and Heart Transplant, Monaldi Hospital, Naples, Italy.
J Card Surg. 2021 Jul;36(7):2355-2364. doi: 10.1111/jocs.15564. Epub 2021 Apr 19.
Right ventricular failure (RVF) is a severe event that increases perioperative mortality after left ventricle assist device (LVAD) implantation. Right ventricular (RV) function is particularly affected by the LVAD speed by altering RV preload and afterload as well as the position of the interventricular septum. However, there are no studies focusing on the relationship between pump speed optimization and risk factors for the development of late RVF.
Between 2015 and 2019, 50 patients received LVAD implantation at San Camillo Hospital in Rome. Of these, 38 who underwent pump speed optimization were included. Post-optimization hemodynamic data were collected. We assessed a new Hemodynamic Index (HI), calculated as follows: , to determine the risk of late RVF, which was defined as the requirement for rehospitalization and inotropic support.
Ten patients had late RVF after LVAD implantation. Five patients required diuretic therapy and speed optimization. Three patients required inotropic support with adrenaline 0.05 μg/kg/min. Two patients needed prolonged continuous venovenous hemofiltration and high dose inotropic support. Multivariate analysis revealed that a low HI (odds ratio 11.5, 95% confidence interval, 1.85-65.5, p [.003]) was an independent risk factor for late RVF after LVAD implantation.
We demonstrated a low HI being a significant risk factor for the development of RVF after LVAD implantation. We suggest implementing HI as a decision support tool for goal-direct optimization of the device aiming to reduce the burden of late-onset RVF during the follow-up.
右心室衰竭(RVF)是左心室辅助装置(LVAD)植入后增加围手术期死亡率的严重事件。LVAD 速度通过改变 RV 前负荷和后负荷以及室间隔的位置,特别影响 RV 功能。然而,目前尚无研究关注泵速优化与晚期 RVF 发展的危险因素之间的关系。
2015 年至 2019 年,50 例患者在罗马圣卡米洛医院接受了 LVAD 植入。其中 38 例接受了泵速优化。收集优化后的血流动力学数据。我们评估了一个新的血流动力学指数(HI),计算如下: ,以确定晚期 RVF 的风险,晚期 RVF 定义为需要再次住院和使用正性肌力支持。
10 例患者在 LVAD 植入后发生晚期 RVF。5 例患者需要利尿剂治疗和速度优化。3 例患者需要肾上腺素 0.05μg/kg/min 的正性肌力支持。2 例患者需要长时间连续静脉-静脉血液滤过和高剂量正性肌力支持。多变量分析显示,低 HI(比值比 11.5,95%置信区间,1.85-65.5,p[.003])是 LVAD 植入后晚期 RVF 的独立危险因素。
我们证明了低 HI 是 LVAD 植入后 RVF 发展的一个显著危险因素。我们建议将 HI 作为一种决策支持工具,用于对设备进行目标导向的优化,以减少随访期间晚期 RVF 的负担。